Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Cash from Operations (2024 - 2026)

Kestra Medical Technologies (KMTS) reported Cash from Operations of 18366000.0 for Q1 2026, down 2.05% year-over-year from 18750448.26 in Q1 2025, and little changed on a QoQ basis from 18343000.0 in Q4 2025.

Kestra Medical Technologies (KMTS) has 3 years of Cash from Operations data on file, last reported at 18366000.0 in Q1 2026.

  • Quarterly Cash from Operations fell 2.05% year-over-year to 18366000.0 in Q1 2026, while the trailing twelve-month figure through Jan 2026 was 87039000.0 (down 27.06% YoY) and the FY2025 annual result came in at 77608000.0, down 7.44% from the prior year.
  • Cash from Operations steadied at 18366000.0 in Q1 2026 per KMTS's latest filing, from 18343000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 14948000.0 in Q2 2024 and bottomed at 26274000.0 in Q3 2025.
  • The 3-year median for Cash from Operations is 18199500.0 (2024), against an average of 19442375.0.
  • Peak annual rise in Cash from Operations reached 1.59% in 2025, while the deepest fall reached 60.93% in 2025.
  • Tracing KMTS's Cash from Operations over 3 years: stood at 18056000.0 in 2024, then retreated by 1.59% to 18343000.0 in 2025, then slipped by 0.13% to 18366000.0 in 2026.
  • Per Business Quant, the three latest KMTS Cash from Operations figures stand at 18366000.0 (Q1 2026), 18343000.0 (Q4 2025), and 26274000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 911.90 Mn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 671.00 Mn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 554.13 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 89.90 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -189.00 Mn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 260.90 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 151.04 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 213.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 118.69 Mn
10 Kestra Medical Technologies 1.13 Bn 840.05 Mn 12.91 Mn -18.37 Mn

Historic Data

Download Data 🔒
DateValue
Jan 31, 2026 -18.37 Mn
Jan 31, 2026 -18.37 Mn
Oct 31, 2025 -18.34 Mn
Oct 31, 2025 -18.34 Mn
Jul 31, 2025 -26.27 Mn
Jul 31, 2025 -26.27 Mn
Apr 30, 2025 -24.06 Mn
Apr 30, 2025 -24.06 Mn
Jan 31, 2025 -18.00 Mn
Jan 31, 2025 -18.00 Mn
Oct 31, 2024 -18.06 Mn
Oct 31, 2024 -18.06 Mn
Jul 31, 2024 -17.50 Mn
Jul 31, 2024 -17.50 Mn
Apr 30, 2024 -14.95 Mn
Apr 30, 2024 -14.95 Mn